IrelandHSE funds Skyclarys for Friedreich’s Ataxia patients in Ireland
The HSE has decided to fund Skyclarys, a drug that will improve the quality of life for patients with Friedreich’s Ataxia in Ireland, a decision welcomed by campaigners.
Quorum · collective opinions
HSE funds Skyclarys for Friedreich’s Ataxia patients
First report 13h agoLast update 13h ago1 takes▲ 1
welcoming drug fundingpositiveShow 1 post
started 13h ago•Last update 13h ago
Patients and campaigners welcome the HSE's decision to fund Skyclarys, emphasizing its positive impact on the quality of life for those with Friedreich’s ataxia.
iWitness comments
No comments yet — be the first to weigh in.